SK BIOPHARMACEUTICALS CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 85,000 KRW | +1.19% |
|
+5.33% | -15.34% |
| Jan. 30 | SK Biopharmaceuticals Swings to Profit in Q4 | MT |
| 2023 | SK Group Advances Net Zero Transition via Key Renewable Energy Deal | MT |
Chart calendar SK Biopharmaceuticals Co., Ltd.
b.IJlqzi5P0Xkf2JjzwYGiidxIi19Xxv_WUeKcBiSJxeA.Y6gN91ss4yllvuDH9_ju-LUQ3gpmqbGlIb3RUF2-qoJv6FKkH3mlA3O0zQ~ddaf6bcb3c7028797506caa2eab541a9
Upcoming events on SK Biopharmaceuticals Co., Ltd.
Past events on SK Biopharmaceuticals Co., Ltd.
| 2024-01-28 11:30 pm | Q4 2023 Earnings Call |
| 2024-01-28 | Q4 2023 Earnings Release |
| 2023-11-08 08:00 pm | Q3 2023 Earnings Call |
| 2023-11-08 | Q3 2023 Earnings Release |
| 2023-10-31 03:10 pm | Targeted Protein Degradation Summit |
| 2023-10-12 12:30 pm | AACR-NCI-EORTC International Conference |
| 2023-09-28 02:50 pm | Discovery on Target Conference |
| 2023-09-27 09:30 am | Discovery on Target Conference |
| 2023-08-09 | Q2 2023 Earnings Release |
| 2023-07-13 10:00 pm | Analyst Meeting |
| 2023-05-10 08:30 pm | Q1 2023 Earnings Call |
| 2023-05-10 | Q1 2023 Earnings Release |
| 2023-03-19 | Q4 2022 Earnings Release |
| 2023-02-08 11:00 pm | Q4 2022 Earnings Call |
| 2023-01-08 | J.P. Morgan Health Care Conference |
| 2022-11-15 | Society for Neuro-Oncology Conference |
| 2022-11-13 | Q3 2022 Earnings Release |
| 2022-08-15 | Interim 2022 Earnings Release |
| 2022-05-15 | Q1 2022 Earnings Release |
| 2022-05-11 09:30 pm | Q1 2022 Earnings Call |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Billions KRW | Released Forecast Spread | 124 | 25,7 31,6 -18.83% | 419 249 68.42% | 246 251 -2.01% | 355 336 5.61% | 485 |
|
EBITDA Billions KRW | Released Forecast Spread | 0,00 | -231 -219 -5.49% | 107 -39,0 373.22% | -118 -100 -17.97% | -22,2 -41,6 46.56% | 58,8 |
|
EBIT Billions KRW | Released Forecast Spread | 0,00 | -239 -229 -4.36% | 95,0 -57,3 265.67% | -131 -114 -15.45% | -37,1 -54,5 31.94% | 42,7 |
|
Earnings before Tax (EBT) Billions KRW | Released Forecast Spread | 0,00 | -240 -243 1.22% | 71,3 1,36 5140.92% | -142 -121 -18.08% | -42,6 -48,7 12.59% | 38,6 |
|
Net income Billions KRW | Released Forecast Spread | 0,00 | -248 -202 -22.86% | 64,8 3,02 2047.21% | -139 -115 -21.28% | -33,9 -44,9 24.5% | 31,7 |
|
EPS KRW | Released Forecast Spread | -1 100 | -3 448 -2 757 -25.06% | 828 18,2 4446.88% | -1 780 -1 485 -19.83% | -420 -576 27.03% | 408 |
| Announcement Date | 14/04/20 | 08/02/21 | 08/02/22 | 09/02/23 | 29/01/24 | - |
Quarterly results
| Fiscal Period | December | 2021 S1 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Billions KRW | Released Forecast Spread | 164 72,2 127.09% | 231 68,0 239.12% | 41,1 45,8 -10.07% | 53,4 54,1 -1.14% | 88,8 74,1 19.88% | 62,8 72,8 -13.72% | 60,8 74,2 -18.08% | 77,0 79,6 -3.22% | 90,3 94,8 -4.74% | 127 111 14.63% | 108 | 115 | 126 | 137 | |
|
EBITDA Billions KRW | Released Forecast Spread | 15,1 | 13,8 | 17,5 | 21,2 | |||||||||||
|
EBIT Billions KRW | Released Forecast Spread | 10,9 -112 109.66% | 134 -29,1 561.22% | -37,1 -29,8 -24.62% | -40,1 -29,7 -34.92% | -9,25 -18,2 49.08% | -44,6 -23,3 -91.44% | -22,7 -26,4 14.18% | -18,9 -16,0 -18.27% | -10,7 -14,5 26.12% | 15,2 2,73 456.61% | 5,99 | 6,58 | 13,3 | 18,2 | |
|
Earnings before Tax (EBT) Billions KRW | Released Forecast Spread | 52,7 6,85 669.07% | -35,0 -30,8 -13.67% | -16,6 -17,1 2.81% | -46,5 -25,1 -85.82% | -2,49 -20,1 87.59% | -25,1 -21,7 -15.58% | -19,8 -18,5 -7.36% | 4,80 1,18 308.17% | 1,78 | 1,30 | 10,6 | 15,2 | |||
|
Net income Billions KRW | Released Forecast Spread | 62,0 -114 154.28% | 47,1 7,00 573.24% | -35,2 -31,2 -12.84% | -15,0 -16,7 10.4% | -43,9 -22,6 -93.77% | -2,37 -19,6 87.91% | -23,3 -20,4 -14.26% | -13,9 -19,4 28.04% | 5,71 2,43 134.58% | 2,90 | 2,40 | 10,8 | 14,7 | ||
|
EPS KRW | Released Forecast Spread | -450 -324 -38.99% | -580 -359 -61.56% | -191 -338 43.55% | -560 -269 -108.49% | -30,0 -288 89.6% | -298 65,9 -552.34% | -235 -333 29.48% | 86,0 47,6 80.56% | -32,9 | 15,6 | 152 | 186 | 160 | ||
| Announcement Date | 10/08/21 | 08/02/22 | 16/05/22 | 11/08/22 | 10/11/22 | 09/02/23 | 10/05/23 | 10/08/23 | 09/11/23 | 29/01/24 | - | - | - | - | - |
More events
Past sector events for SK Biopharmaceuticals Co., Ltd.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- A326030 Stock
- Calendar SK Biopharmaceuticals Co., Ltd.
